• Follow us
  • EN
    Flag Indonesia ID
    Flag English EN
Untitled design (6)
  • About Us
    • Company Profile
      • PT Bio Farma (Persero)
      • Kimia Farma Tbk (KAEF)
      • Indofarma Tbk (INAF)
      • PT INUKI (Persero)
    • History
    • Management
      • Commisioners
      • Directors
    • Research & Development
    • Our Achievement
      • Awards
      • Certification
    • Report
      • Annual Report
      • Sustainability
  • Product & Services
    • Our Distribution
    • Product & Services
      • Life Sciences
      • Providers of Health Services & Products
      • Trade, Distribution of Medicines & Medical Devices
    • Immunization Services
    • Cervical Cancer Screening Service
    • FAQ
  • Media & Information
    • News
      • All News
      • Global Roles
      • Products & Services
      • CSR
    • Health Articles
    • Health FAQ
    • Our Procurement
  • Corporation
    • Good Corporate Governance
    • Our Commitment
    • CSR
    • LHKPN
      • Lapor
  • Career
    • Recruitment
  • PPID
  • Contact Us
search

TT Vaccine

Wednesday, 25 November 2015

Description TT vaccine is a white homogeneous colloidal suspension in glass vial, contains purified tetanus toxoid, which is adsorbed onto aluminum phosphate. Indication Active immunization against tetanus and neonatorum tetanus by immunizing child bearing age woman. Composition Each dose (0.5 mL) contains : Active ingredient : Purified tetanus toxoid 10 Lf. Excipients : Aluminum phosphate 1.5 mg, Thimerosal 0.05 mg Administration TT immunization for the prevention of tetanus / neonatorum tetanus consists of two primary doses of 0.5 mL given intramuscularly at least four weeks apart followed by the third dose at least 6 months later. Storage The vaccine must be stored at temperatures between +2oC and +8oC. Do not freeze. Expiry date 3 years. Presentation Box : 10 vial @ 5 mL (10 doses)

tt DESKRIPSI Vaksin TT merupakan suspensi koloidal homogen berwarna putih susu dalam vial gelas, mengandung toksoid tetanus murni, teradsorbsi kedalam aluminium fosfat. KOMPOSISI Tiap dosis (0,5 mL) mengandung : Zat berkhasiat:

  • Toksoid tetanus murni     10 Lf

Zat tambahan:

  • Aluminium fosfat        1,5 mg
  • Thimerosal            0,05 mg

INDIKASI Vaksin digunakan untuk pencegahan terhadap tetanus dan perlindungan terha-dap tetanus neonatorum pada wanita usia subur. CARA KERJA OBAT Merangsang tubuh membentuk antibodi terhadap tetanus. POSOLOGI

  • Imunisasi  TT  untuk  pencegahan  terhadap tetanus/ tetanus neonatorum terdiri  dari  2  dosis  primer  @  0,5  mL yang diberikan secara intramuskular dengan interval 4-6 minggu, diikuti dengan dosis ke tiga 6 bulan berikutnya.
  • Vaksin TT dapat diberikan bersamaan dengan vaksin BCG, Campak, Rubella, Mumps, Polio (OPV atau IPV), Hepatitis B, Haemophilus Influenzae tipe b, dan Yellow Fever pada lokasi penyuntikan yang berbeda, serta suplemen vitamin A.

EFEK SAMPING Bersifat ringan dan jarang, seperti sakit dan kemerahan pada lokasi suntikan yang bersifat sementara, serta kadang-kadang demam. Aman diberikan selama masa ke- hamilan. KONTRAINDIKASI

  • Reaksi berat terhadap dosis vaksin TT sebelumnya
  • Hipersensitif terhadap komponen vaksin
  • Imunisasi  sebaiknya  tidak  diberikan pada keadaan demam atau infeksi akut. Pada demam ringan (minor afebrile illness) seperti infeksi ringan pada pernafasan bagian atas, imunisasi dapat diberikan.

DEFISIENSI SISTEM KEKEBALAN Individu yang terinfeksi HIV asimtomatis maupun simtomatis, harus divaksinasi TT menurut jadwal yang telah ditetapkan. INTERAKSI OBAT Tidak ada interaksi obat

PENYIMPANAN
  • Vaksin  BIO-TT  harus  disimpan  pada  suhu antara +2° s/d +8°C.
  • TIDAK BOLEH DIBEKUKAN.
  • Masa daluarsa 3 tahun

KEMASAN Dus : 10 ampul @ 0,5 mL (1 dosis)

  • Share to:
Download

Latest News

DSC09771
Tuesday, 9 December 2025
Bio Farma Receives Official Visit from the Governor of Victoria to Strengthen Strategic Cooperation in Health and Biotechnology
DCVMN
Wednesday, 5 November 2025
26th DCVMN AGM Successfully Held: Bio Farma and DCVMN Strengthen Global Collaboration to Build a Resilient and Inclusive Vaccine Ecosystem
WhatsApp Image 2025-10-30 at 13.39.28
Thursday, 30 October 2025
Strengthening Global Collaboration to Build a Resilient and Sustainable Vaccine Ecosystem
View more

Logo biofarma

Call Center 1500810

Head Office

Jl. Pasteur No. 28, Bandung 40161,
Jawa Barat Indonesia
+62 22-2033755
+62 22 - 2041306
mail@biofarma.co.id

Breeding Facility Bio Farma

Jl. Kolonel Masturi Kav 10. Desa Kertawangi kec. Cisarua
Jawa Barat

Bio Farma Representative Office

Gd. Pakarti centre Lantai 7
Jln. Tanah Abang 3 no.23-27
Jakarta Pusat

Information

  • Good Corporate Governance
  • Our Procurement
  • FAQ
  • Vaccine Production
  • Your Career

 

  • Contact Us
  • E-PPID
  • Announcement
  • Media Release

Quick Links

  • Portal BUMN-Bio
  • Kemenkes RI
Copyright © 2026. All Rights Reserved by Bio Farma

Change Language

EN
  • About Us
    • Company Profile
      • Company Profile
      • PT Bio Farma (Persero)
      • Kimia Farma Tbk (KAEF)
      • Indofarma Tbk (INAF)
      • PT INUKI (Persero)
    • History
    • Management
      • Commisioners
      • Directors
    • Research & Development
    • Our Achievement
      • Awards
      • Certification
    • Report
      • Annual Report
      • Sustainability
  • Product & Services
    • Our Distribution
    • Product & Services
      • Life Sciences
      • Providers of Health Services & Products
      • Trade, Distribution of Medicines & Medical Devices
    • Immunization Services
    • Cervical Cancer Screening Service
    • FAQ
  • Media & Information
    • News
      • All News
      • Global Roles
      • Products & Services
      • CSR
    • Health Articles
    • Health FAQ
    • Our Procurement
  • Corporation
    • Good Corporate Governance
    • Our Commitment
    • CSR
    • LHKPN
      • Lapor
  • Career
    • Career
    • Recruitment
  • PPID
  • Contact Us
  • Follow us
Change Language
  • Flag Indonesia ID
  • Flag English EN